FFPE Total RNA Purification Kit for Formalin Fixed Paraffin Embedded Tissue (includes DNAse) Add to Cart
• Extract total RNA (large mRNA, rRNA, microRNA, siRNA) from FFPE samples
• Rapid spin column format
• No phenol:chloroform extraction step
• Isolated RNA is of high yield, quality and integrity
Norgen’s FFPE RNA Purification Kit provides a rapid method for the isolation and purification of total RNA (including microRNA) from formalin-fixed paraffin-embedded (FFPE) tissue samples.
Using formalin to fix tissues leads to crosslinking of the RNA and proteins, and the process of embedding the tissue samples can also lead to fragmentation of the RNA over time. Norgen’s FFPE RNA Purification Kit provides conditions that allow for the partial reversing of the formalin modifications, resulting in a high quality and yield of RNA.
The kit is able to purify all sizes of RNA, from large mRNA and ribosomal RNA down to microRNA (miRNA) and small interfering RNA (siRNA), depending on the age of the FFPE tissue as fragmentation of the RNA is known to occur over time.
Figure 1: High Quality and Yield of Total RNA
Total RNA was isolated from equal amounts of an FFPE tissue sample using Norgen’s FFPE RNA Purification Kit and a leading competitor´s kit. The purified RNA was then resolved on an Agilent BioAnalzyer. As it can be seen, Norgen not only isolated higher yields of total RNA, but the RNA was also of a higher quality as evidenced by the higher RIN values obtained with Norgen’s RNA.
Figure 2: High Yield of a Diversity of RNA Species
Total RNA was isolated from equal amounts of an FFPE tissue sample using Norgen’s FFPE RNA Purification Kit and a leading competitors kit. The purified RNA was then used as the template in a RT-qPCR for detecting the beta-actin gene (Panel A) and for detecting miR-21(Panel B). In both graphs the blue lines correspond to Norgen isolated-RNA and the green lines correspond to competitor-isolated RNA. As it can be seen, Norgen’s kit isolated higher yields of RNA in both cases, as indicated by the higher C T values of the blue lines. Also, Norgen’s kit successfully isolated not only large RNA (Panel A) but also microRNA (Panel B), indicating the diversity of RNA species isolated.
FFPE RNA Kit Specifications (per prep)
FFPE RNA Kit Applications
• qRT-PCR and RT-PCR
• Expression Array Profiling
• Primer Extension
- Assawawongkasem, N., Suriyaphol, G., Srisuwatanasagul, S., Theerawattanasirikul, S., & Sailasuta, A. (2016) Involucrin Expression and Association with Ki-67 in Paraffin Embedded Tissue of Canine Skin Tumors: A Retrospective Study. The Thai Journal of Veterinary Medicine
- Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D. (2016) miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer. OncoTargets and Therapy
- David A. Armstrong, Benjamin B. Green, John D. Seigne, Alan R. Schned and Carmen J. Marsit. (2015) MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Molecular Cancer
- Márquez J, Mena J, Hernandez-Unzueta I, Benedicto A, Sanz E, Arteta B, Olaso E. (2015) Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice. Oncology Reports
- Zhuo Wang, Zhong Deng, Nadia Dahmane, Kevin Tsai, Pu Wang, Dewight R. Williams, Andrew V. Kossenkov, Louise C. Showe, Rugang Zhang, Qihong Huang, José R. Conejo-Garcia, and Paul M. Lieberman. (2015) Telomeric repeat-containing RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes. PNAS
- C Wu, S Mikhail, L Wei, C Timmers, S Tahiri, A Neal, J Walker, S El-Dika, M Blazer, J Rock, D J Clark, X Yang, J L Chen, J Liu, M V Knopp and T Bekaii-Saab. (2015) A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers. British Journal of Cancer
- Patnaik, Santosh, Mallick, Reema, Kannisto, Eric MS, Sharma, Rohit, Bshara, Wiam, Yendamuri, Sai M, Dhillon, Samjot Singh. (2015) MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies. Journal of Thoracic Oncology
- Rajyasree Emmadi, Emanuele Canestrari, Zarema H. Arbieva, Wenbo Mu, Yang Dai, Jonna Frasor, Elizabeth Wiley. (2015) Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas. PLOS ONE
- Tam S, Borja R, Tsao M, and McPherson J. (2014) Robust global microRNA expression profiling using next-generation sequencing technologies. Laboratory Investigation
- Shi-Dong Ma, Xuequn Xu, Julie Plowshay, Erik A. Ranheim, William J. Burlingham, Jeffrey L. Jensen, Fotis Asimakopoulos, Weihua Tang, Margaret L. Gulley, Ethel Cesarman, Jenny E. Gumperz and Shannon C. Kenney. (2014) LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. The Journal of Clinical Investigation
- Ludyga N, Grônwald B, Azimzadeh O, Englert S, H?fler H, Tapio S, Aubele M. (2012) Nucleic acids from long-term preserved FFPE tissues are suitable for downstream analyses. Virchows Arch
- Patnaik SK, Kannisto E, Yendamuri S. (2012) Factors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections. BMC Research Notes
- Patnaik S, Kannisto E, Mallick R, Yendamuri S. (2011) Overexpression of the Lung Cancer-Prognostic miR-146b MicroRNAs Has a Minimal and Negative Effect on the Malignant Phenotype of A549 Lung Cancer Cells. PLoS One